# Arcuate Therapeutics, Inc. — Form D

Arcuate Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-09. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-10-09
- Form: D
- Accession: 0001790236-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 3
- Date of first sale: 2019-09-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-350699

## Issuer

- Name: Arcuate Therapeutics, Inc.
- CIK: 0001790236
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116
- Phone: 617-778-2580

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Levin | Director | BOSTON, MA |
| Joshua Resnick | Director | New York, NY |
| Aaron Bergener | Executive Officer | Boston, MA |
| Andrew Levin | Executive Officer | BOSTON, MA |
| Sarah Reed | Executive Officer | Boston, MA |
| James Schneider | Executive Officer | Boston, MA |

## More

- [CIK 1790236 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1790236&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001790236-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.